Feedback / Questions
ropidoxuridine (IPdR) - Shuttle Pharma, National Cancer Institute
https://www.globenewswire.com/news-release/2025/05/08/3077667/0/en/Shuttle-Pharma-FDA-Orphan-Drug-Nears-Patient-Enrollment-Milestone-for-Phase-2-Clinical-Trial.html
May 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next